The standard 6 core biopsy, with an accuracy about 16%, has been replaced by 12 and 24 needle cores, improving the diagnostic rate. 1/3 of tumors will occur deeper than the normal thrust of the guide and will be missed unless the sonogram or MRI demonstrates a remote lesion (which are not palpable by the DRE as they lie far from the examining finger.) Biopsies do leave cancer cells in the needle tract which may also enter the blood stream producing tumors in distant organs.
MRI is the current gold standard but is less accurate in the presence of prostatitis (a common low grade infection) that has few symptoms. Sonograms predicting this inflammation can prevent misdiagnoses.
Radical surgery is time honored and frequently displays more aggressive tumors than predicted by earlier biopsies. Side effects are impotence and incontinence.
Recurrence may occur in up to 20% of high grade tumors.
Various forms of radiation from radioactive seeds to focused beams attempting to spare adjacent tissues have a high cure rate. Side effects are impotence and incontinence. Recurrence may occur up to 35% of cases of higher grade tumors.
BARD CANCER DIAGNOSTICS is founded on the commitment to explore and implement the latest diagnostic technologies as a means of building the proper treatment strategy of many types of cancers. We also specialize in the PREVENTION solutions for our patients who strive to maintain a health-conscious lifestyle as well as those who are at increased risk of certain diseases by confirming that their efforts to prevent disease are working.
BARD CANCER DIAGNOSTICS
121 E. 60th St. Suite #6A New York, NY 10022